Background. The study determined (i) whether or not quartan malaria nephropathy (QMN) is still a major cause of childhood nephrotic syndrome (CNS) in Nigeria, (ii) secondary causes other than QMN and their associated glomerular pathology and (iii) renal and patient outcome. Methods. The study was a prospective non-randomized study of consecutive cases of secondary CNS. Patients with idiopathic CNS were excluded. Results. Twenty-four of 78 (30.8%) CNS cases were of secondary aetiology. Overall mean ages at onset of secondary CNS aetiology and CNS onset were 8.97 ± 3.59 (1-15.3) and 9.95 ± 3.15 (5-15.3) years, respectively. Male (14)/female (10) ratio was 1.4. Secondary causes comprised systemic lupus erythematosus (SLE, 37.5%), sickle cell anaemia (SCA, 16.7%), hepatitis B virus (HBV, 16.7%) infection, Churg-Strauss syndrome (12.6%), SLE/human immunodeficiency virus infection (4.2%), rhabdomyosarcoma (4.2%), bee stings (4.2%) and Addison's disease (4.2%). The overall cumulative complete remission (CR) rate was 88.0%. Remission was sustained in 11 of 16 (68.8%) CR patients, while one patient (6.25%) relapsed; the remaining four patients (24.95%) were yet to attain sustained remission. Median relapsefree period was 10.5 (0.75-25) months. Cumulative renal survival was 75.2% at 3 years. Three patients were lost to follow-up, while two died. Overall cumulative patient survival probability at 36 months was 90.8%. All patients were followed for a median period of 12.5 (0.11-36.0) months. Conclusion. Overall outcome of CNS has improved significantly compared to the 1960s and 1970s when the poor outcome of QMN was the predominant glomerular lesion in Nigeria. While quartan malaria-associated nephrotic syndrome has become a rare clinical entity, SLE, SCA and HBV infection have become the major secondary aetiologies of CNS in Nigeria.
Introduction
Compared to children in other continents [1] [2] [3] [4] , secondary nephrotic syndrome (SNS) is commoner in African children [5] [6] [7] [8] [9] [10] [11] [12] 
than idiopathic nephrotic syndrome (INS).
Most studies on nephrotic African children implicated infectious agents [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] . Quartan malaria nephropathy (QMN) due to Plasmodium malariae [5] [6] [7] [8] , membranous nephropathy (MN) due to hepatitis B virus (HBV) infection [9] and diffuse proliferative glomerulonephritis (DPGN) due to group A β-haemolytic streptococci and syphilis [10] [11] [12] were the frequent glomerular morphologic lesions in a number of studies from Africa. QMN is a persistent and progressive proteinuric kidney disorder due to P. malariae-induced glomerular damage; it is characterized by glomerular capillary wall thickening involving the subendothelial aspect of the basement membrane, producing either a double contour or a plexiform arrangement of periodic acid-Schiff (PAS)-positive argyrophilic fibrils (light microscopy), granular deposits of IgG, IgM and C3 complement along the glomerular basement membrane (immunofluorescence) and glomerular basement membrane lacunae on electron microscopy. There is also tubular atrophy [7] . Most of the works on QMN in Nigeria were done in the 1960s and 1970s in Ibadan, south-western Nigeria [5-7, 13, 15] . In one such study, quartan malaria (QM) was the aetiologic agent in 81.0% of all cases of childhood-onset nephrotic syndrome (CNS) [7] . These studies revealed very dismal response to steroids and/or other forms of immunosuppressive therapy. Renal outcome was equally poor with most cases progressing to chronic renal failure (CRF) deaths within 5 years of illness onset [6, [13] [14] [15] . Ironically, recent studies from Ibadan showed high prevalence of childhood-onset INS with good steroid response [16, 17] . This contrasts sharply with the previously reported high prevalence of QMN from the same unit [5] [6] [7] . Recent data on QMN from Nigeria are lacking. The last known published work on QMN from Nigeria was in 1990 from northern Nigeria [14] . This prospective study was conducted to determine (i) whether or not QMN is still a major cause of childhood SNS in south-western Nigeria,
(ii) secondary causes other than QMN and associated glomerular pathology and (iii) renal and patient outcome in childhood SNS in Ile-Ife, south-western Nigeria-a town located 75 km from Ibadan where previous studies on QMN in Nigeria were largely done.
Materials and methods
This prospective study of consecutive cases of CNS with established secondary aetiology was conducted (June 2000 to June 2008) at the Paediatric Nephrology and Hypertension Unit of the Obafemi Awolowo University Teaching Hospitals Complex, Osun State, Nigeria. The state has a population of 1 530 000 children and adolescents who are 16 years old and less. Ethical approval and parental/guardians' consent were obtained. The study conformed to the provisions of the revised Declaration of Helsinki, Edinburg, 2000.
Definitions
Nephrotic syndrome (NS) markers were oedema, plasma albumin <25 g/L and proteinuria ≥40 mg/m 2 /h or a urinary protein-creatinine ratio (UPCR) ≥200 mg/mmoL by quantitative assessment [18] or ≥3+ proteinuria by dipstick. Complete remission (CR) was a proteinuria <4 mg/m 2 /h or UPCR <20 mg/mmoL or 0/trace proteinuria by dipstick for three consecutive days [18] . Relapse was recurrence of proteinuria in excess of 40 mg/m 2 /h or UPCR ≥200 mg/mmoL or ≥2+ by dipstick for three consecutive days after an initial CR. Sustained CR was absence of relapse for at least 6 months. Partial remission (PR) was reduction in proteinuria level to 4-39 mg/m 2 /h or a UPCR of 20-199 mg/mmoL or 1+/2+ proteinuria by dipstick. Significant microhaematuria and pyuria were urinary red blood cells (RBC) ≥5/ high power field (HPF) and white blood cells (WBC) ≥10/HPF, respectively. Renal insufficiency was an estimated glomerular filtration rate (eGFR) <80 mL/min/1.73 m 2 . Poor renal survival was eGFR that is persistently <80 mL/min/1.73 m 2 for at least 3 months. CRF referred to eGFR <60 mL/min/1.73 m 2 and end-stage renal disease (ESRD), eGFR <15 mL/ min/1.73 m 2 for 3 months or more. All newly confirmed cases of SNS aged 16 years and below were recruited. Patients with INS were excluded from the study.
Clinical evaluation and investigation
Gender, age at NS onset, age at diagnosis, vital signs, anthropometry and hypertension (HTN) were assessed. HTN was diagnosed when the systolic and/or diastolic blood pressure (BP) was more than the 95th percentile for age, gender and height [19] . Other obtained data were treatment given, treatment complications, comorbidities, remission onset time, remission duration, admission duration, outcome and follow-up. Every patient was interviewed, examined and investigated for evidence of Alport's syndrome, obesity, congenital cyanotic heart disease, infections like P. malariae or QM, syphilis, schistosomiasis, viral hepatitis B/C, filariasis and human immunodeficiency virus (HIV). Clinical and laboratory information were also obtained regarding mercury containing soap/cream use, exposure to lead, bee sting, diabetes mellitus, sickle cell disease (SCD), small-to medium-sized systemic vasculitides, systemic lupus erythematosus (SLE) using the American College of Rheumatology (ACR) diagnostic criteria [20] , Henoch-Schonlein purpura and any other possible secondary aetiology of NS. Renal ultrasound, full blood counts and differentials, platelets, plasma and urinary biochemical evaluations were performed. eGFR was determined by the Schwartz formula [21] . Diagnosis and staging of chronic kidney disease (CKD) was according to the Kidney Disease Outcomes Quality Initiative guidelines [22] . All confirmed cases of SNS had pretreatment percutaneous renal biopsy. Tissue sections were 2-3 μm thick. Histopathologic examinations were performed along standard lines by a renal pathologist. Five or more glomeruli per renal tissue specimen were regarded as adequate for reporting.
Treatment, follow-up and outcome Treatment was individualized and according to aetiology of the NS. The patients were seen in the clinic every 1-3 months. At each clinic visit, every patient was evaluated for weight, height, vital signs, oedema, ascites and proteinuria. At follow-up, UPCR and eGFR were assessed initially at 3 months and subsequently every 6 months, provided there were no indications for an earlier assessment. The outcome indices in this study were CR, PR, relapse-free period, renal survival, patient survival, study exit by reasons of death or voluntary discharge and loss to follow-up.
Statistical analysis
The SPSS 15.0 statistical software package for Windows Evaluation Version (SPSS 2006 Inc.) was used for the analysis. Descriptive statistics used comprised mean, standard deviation (SD), median, percentages and proportions. The comparative statistics used were Kaplan-Meier survival analysis and the log-rank test. P value <0.05 was considered statistically significant.
Results
Overall, CNS accounted for 78 of 6 200 (1.26%) paediatric admissions. Of these, 24 (30.8%) were of secondary aetiology, while the rest were idiopathic or primary. The incidence and prevalence of SNS were 0.2/100 000/year and 1.57/100 000, respectively. The overall mean ages ± SD at onset of the disease causing the NS and at NS onset were 8.97 Table 1 shows the prevalence of each of the identified secondary causes of the NS in the patients and their associated glomerular lesions. Thick and thin blood film examinations for the band forms of QM parasites in every patient yielded negative results persistently. Moderate falciparum malaria parasitaemia (2+ or 11-100 parasites/100 high-power fields) was found in one of four sickle cell anaemia (SCA) patients. Details of some of the laboratory results are shown in Table 2 , while the prevalence of each of the observed comorbidities is shown in Figure 1 . Table 3 summarizes the various treatment modalities received by the patients. The overall cumulative CR probability at the end of follow-up was 88.0%; the treatment survival times before CR are shown in Figure 2 . Median time to CR was 150 (95% CI: 48-252) days. Times to CR were significantly shorter in patients with sickle cell nephropathy compared to other aetiologies (log rank P = 0.001, Figure 3 ). Remission was sustained in 11 of 16 (68.8%) patients that achieved complete remission, while one patient (6.25%) relapsed. Median relapse-free period was 10.5 (0.75-25) months. Renal outcome was poor in four patients (24.8%); the overall cumulative renal survival curve is shown in Figure 4 . Those with poor renal survival had CKD stage 2 with a median eGFR of 72 (67-79) mL/min/1.73 m 2 . The complications of immunosuppressive therapy included sepsis (n = 7), oral thrush (n = 2), prednisolone-associated HTN (n = 6) and prednisolone-induced obesity (n = 4). Two of four patients with HBV infection-associated NS had elevated baseline alanine aminotransferase (ALT, 45-53 IU/L) that normalized in addition to seronegative HBsAg tests 8-12 months post treatment. An SLE patient was classified SLE/HIV because she became seropositive for HIV 3 months after she was sexually abused; baseline HIV test was negative. Three patients were lost to followup, while two died. One patient died of lupus carditis, whilst the other who had SCA died from a combination of septicaemia, hepatic failure and acute kidney injury (AKI). The eGFR in the surviving SCA patients ranged between 100 and 137 mL/min/1.73 m 2 at 6-12 follow-up months. All patients were followed for a median period of 12.5 (0.11-36.0) months. Overall cumulative patient survival probability at the end of 36 follow-up months was 90.8%.
Discussion
Compared to idiopathic nephrotic syndrome, SNS is a rare clinical event in children. In non-Africans, SNS (5%) is 19 times less common than INS (95%) [23] [24] [25] ; in Nigeria, however, the preponderance of INS over SNS is less pronounced with the INS being 2.5 (71.4%) times commoner than SNS (28.6%) [26] . In this study, INS (69.2%) was just 2.2 times commoner than SNS (30.8%), thus in agreement with the general trend but at variance with the previous report from the same south-western Nigeria where SNS (81.0%) was found to be 4.3 times commoner than INS (19.0%) [7] ; in the latter study, QMN was the sole secondary agent in 81.0% of all CNS cases. QM parasitaemia was found in 88.0% of the nephrotic children in that study.
High prevalence of baseline hypertension, haematuria, azotaemia and low eGFR reflects the severe nature of the NS aetiologies and the need for early diagnosis and informed therapeutic interventions to limit comorbidities and abort disease progression and prevent mortality. The patients were neither overweight nor obese (BMI: 11.84-23.53kg/m 2 ); therefore, the HTN and the focal segmental glomerulosclerosis (FSGS) lesion found in some of the patients could not have been partly due to any of the nutritional problems. The comorbidities were quite severe, leading to two deaths, one each from lupus carditis and AKI with associated septicaemia and hepatic failure. While falciparum malaria continues to be causally associated with AKI in Nigeria [27, 28] , the light on QM as aetiologic agent in childhood NS appeared to have dimmed. This is because in none of the recent CNS studies from Nigeria was QM identified as causative [16, 17, 26] . In this study, definitive aetiologic agents other than QM were causally associated with the NS; and in none of these patients was the glomerular morphology in consonance with the characteristic descriptions of QMN [7] . The lack of QM in this and other recent studies from Nigeria might be due to improved living standards, healthcare access, better understanding of clinical features of malaria and treatment and ready access to antimalarials contrary to what it was in the 1960s and 1970s when medicare access was poor. In the country today, every fever is regarded as Ibuprofen + spironolactone + intravenous (IV) dexamethasone and IV cyclophosphamide infusion in pulse doses for six doses followed by oral prednisolone and cyclophosphamide (n = 1) Prednisolone + oral cyclophosphamide (=1) Prednisolone + valsartan (n = 2) Prednisolone + lisinopril (n = 2) Prednisolone + ibuprofen (n = 2) Sickle cell anaemia Lisinopril + IV dexamethasone + IV cyclophosphamide infusion followed by oral cyclophosphamide and prednisolone (n = 1) Ibuprofen + spironolactone (n = 1) Prednisolone + lisinopril (n = 1) Lisinopril (n = 1) Hepatitis B virus Lisinopril + lamivudine (n = 1) Daily oral lamivudine + cyclophosphamide + spironolactone (n = 3) Allergic granulomatous eiosinophilic angiitis (Churg-Strauss syndrome)
Spironolactone + IV dexamethasone + IV cyclophosphamide infusion followed by oral cyclophosphamide and prednisolone (n = 1) Prednisolone (n = 2) SLE + Human immune deficiency virus infection Lisinopril + IV dexamethasone + IV cyclophosphamide infusion followed by oral cyclophosphamide and prednisolone and highly active anti-retroviral drugs that comprised lamivudine 60mg + stavudine 12mg + nevirapine 100mg (n = malaria by the general population and is first and foremost treated with antimalarials that are purchased across the counter without prescription. It is possible therefore that circulating QM parasites are constantly destroyed by this healthcare seeking behaviour thereby preventing the parasites from having long enough contact with the host immune system to evoke that kind of immune response that would cause a renal damage leading to NS. Similarly, a study of NS in Ghanaian children [29] as well as a recent exhaustive review of malaria-associated renal damage in children [30] found no recent evidence for QMN. An underlying disorder that might be identified in less than 5% of cases of NS in other populations includes SLE, HenochSchonlein purpura, amyloidosis and infection with HIV, parvovirus B19 and hepatitis B and C viruses [23] [24] [25] . SLE was the leading aetiology in this study, accounting for 37.5% and 11.54% of all SNS and all cases of childhood NS, respectively. Renal comorbidities are common, occurring in 20-80% of paediatric SLE cases [31] [32] [33] . Our data showed that the glomerular pathologies were predominantly of the proliferative types with both active and chronic lesions. The diverse treatment protocols received by the patients reflected the diverse clinical forms of presentation and disease activity in the patients as well as the need for abortion of renal disease progression with the addition of spironolactone, lisinopril or valsartan. SCA is the leading hereditary anaemia in Nigerian children; it is estimated that 19-33% of the population carries the haemoglobin S gene, while the homozygous disease occurs in 2% of Nigerian children [34, 35] . Severe renal structural distortions at glomerular, tubulointerstitial and vascular levels with accompanying functional perturbations are well described in both children and adults with sickle cell disease (reviewed in [36] ). Glomerular lesions leading to significant proteinuria and the NS that have been reported in children and adults with SCA include FSGS, membranoproliferative glomerulonephritis (MPGN) and mesangial proliferative glomerulonephritis (MesPGN); by and large, the FSGS lesion is most frequent [36] . A functional perturbation of distorted glomerular structure due to SCA is the NS; this has been reported in 3.3-3.8% of all cases of childhood NS [37, 38] . In this study, SCA accounted for 5.2% of all cases of childhood NS, and FSGS was the commonly observed glomerular lesion. The glomerular lesions did not impact negatively on treatment survival times as all patients significantly achieved CR within 3-21 days of treatment compared to patients with other aetiologies that had much longer treatment survival times ( Figure 3) . One of the deaths in this study occurred in an SCA patient 6 months after NS onset. The three survivors are in sustained remission with normal eGFR. In Africa, it is estimated that about 10% of people infected with HBV develop chronic HBV infection [39] . Immune-complex-mediated HBV infection-associated nephropathy may occur in individuals that are chronically infected [40] . MN is commonly associated with HBV infection [9, [40] [41] [42] , but other glomerular variants have been described [40] [41] [42] . In South Africa and Namibia, HBV infection was associated with 34.3% and 41.4% of all cases of childhood NS, respectively [9, 42] . In South Africa, all the HBV cases were found in black children aged 6-8 years with MN as the sole lesion [9] . The prevalence of HBV-associated nephropathy and NS in this study was not as high (5.2%); but the age range (5-8 years) was similar to South African children's. Among the Namibian children with HBV infection, the glomerular pattern was MN (89.7%), FSGS (3.43%), MPGN (3.43%) and ESRD (3.43%). Among the Chinese children, 71.8% were due to MN, while MesPGN (10.9%), MPGN (9.4%), minimal change disease (MCD) (6.3%) and FSGS (1.6%) accounted for the rest [41] . The pattern in our patients is similarly a composite of glomerular lesions. Whatever the treatment modality employed, the primary therapeutic goals should be suppression of viral replication and prevention of the development of fibrosis in any patient; seroconversion from HBsAg positivity to HBsAb positivity is the optimal goal of therapy but is rarely achieved [43] . Several drugs including interferon alpha-2a and -2b and lamivudine are now available for the treatment of HBV infection. Lamivudine-a cytosine analogue that inhibits HBV reverse transcriptase-was elected for treatment in this study because of its ready availability; it has been widely used in HBV infection, particularly for renal patients, given its efficacy and tolerability [43] . Lamivudine induces both seroconversion and a histological response in addition to reducing HBV DNA; it was found to be effective both in this regard and at normalizing ALT level in post-renal transplant patients [44, 45] . With our lamivudine-based protocol, two of the four HBV-associated NS patients were able to achieve complete remission within 10-150 days; a negative HBsAg serology test and normal ALT level were achieved after 8-12 months of treatment in the two patients; the remaining two patients are in partial remission. With addition of HBV vaccination to the country's childhood immunization programme, it is expected that the incidence of HBV-associated nephropathy will dwarf considerably as was the case among Chinese children [41] . Three of our patients who satisfied at least four of six ACR diagnostic criteria [46] were diagnosed with allergic granulomatous eosinophilic angiitis or Churg-Strauss syndrome (CSS); it is a rare pauci-immune inflammatory disorder of smallto medium-sized blood vessels that is rarely diagnosed in black African children. Response to treatment was quite good with CR in two patients within 5-56 days. Remission was partial in one patient. Although FSGS, MesPGN/FSGS and MesPGN were the lesions in this study, renal lesions in CSS are usually non-specific [47] . The SLE/HIV patient attained partial remission (1+) within 5 weeks of treatment with prednisolone but reverted to heavy proteinuria (4+) by the end of the third month of prednisolone treatment; it coincided with the time that she became seropositive for HIV infection. Baseline renal pathology in this patient was in keeping with class IV lupus nephritis (LN IV-G [A]) without the features of HIV-associated nephropathy; renal biopsy was not repeated. She has received highly active antiretroviral treatment for 31 months in addition to steroids, lisinopril and cyclophosphamide with partial remission (2 +). We believed the HIV infection made the proteinuria worse and less responsive to therapy. The patient with bee sting-associated NS was quite problematic; he has failed to respond to treatment; a more aggressive treatment combination may have to be tried. Rhabdomyosarcoma is a rare cause of proteinuric nephropathy; the only case that has been reported so far in the English literature had MN as the glomerular lesion [48] , while FSGS was the lesion in our patient. With pulse doses of intravenous cytotoxic drugs directed at the tumour, over a 15-month period, we were able to induce both tumour and proteinuria remission in the child with urinary bladder embryonal rhabdomyosarcoma. The patient has been followed up for 34months and has remained in both sustained tumour and proteinuria remission. Addison's disease is a rare endocrinopathy; primary adrenocortical disorder may rarely be due to tuberculosis, acquired immune deficiency syndrome, fungal infection and metastatic cancers (reviewed in [49] ). Addison's disease is most often attributed to autoimmune disorders; autoimmune antibodies directed against the adrenal gland as well as other organ systems, namely the pancreas, thyroid gland, red blood cells and the ovaries are common [49] . Association with nephrotic syndrome is unknown. We speculate that autoantibodies caused Addison's disease and NS in this child. Treatment with prednisolone and cyclophosphamide led to CR and clinical improvement after an initial prednisolone resistance. This study shows that, with a CR rate of 88.0%, renal survival of 75.2% and patient survival of 90.8%, the overall outcome of SNS has improved significantly compared to the 1960s and 1970s when QMN was the predominant glomerular lesion in Nigeria. During the QMN era, treatment response and renal survival were very dismal; and patient outcome was most times catastrophic within 3-5 years of illness onset [6, [13] [14] [15] . While quartan malaria-associated NS has become a rare clinical entity, SLE, SCA and HBV infection have become the major secondary aetiologies of CNS in south-western Nigeria.
